Who
In numbers
- Trades disclosed
- 18
- Buys
- 8
- Sells
- 0
- Bought
- $12K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 11 Jun 2014
- Last trade
- 15 Apr 2026
- Last filed
- 16 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Apr 2026filed 16 Apr 2026 | ICCC ImmuCelloption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —11,933 at $0.00 | filing |
| 15 Apr 2026filed 16 Apr 2026 | ICCC ImmuCelloption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —11,933 at $0.00 | filing |
| 16 Apr 2025filed 14 Apr 2026 | ICCC ImmuCelloption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 16 Apr 2025filed 14 Apr 2026 | ICCC ImmuCelloption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 20 Sep 2024filed 24 Sep 2024 | ICCC ImmuCelloption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | $36K10,000 at $3.60 | filing |
| 15 Dec 2022filed 24 Jan 2023 | ICCC ImmuCelloption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | $65K10,000 at $6.52 | filing |
| 17 Jun 2021filed 21 Jun 2021 | ICCC ImmuCelloption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | $100K10,000 at $10.04 | filing |
| 11 Mar 2019filed 13 Mar 2019 | ICCC ImmuCelloption or derivative · Diagnostics & Labs | SEC FORM 4 Code D | $52K10,731 at $4.80 | filing |
| 11 Mar 2019filed 13 Mar 2019 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Code A | $20K4,269 at $4.80 | filing |
| 19 Mar 2018filed 21 Mar 2018 | ICCC ImmuCelloption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | $106K15,000 at $7.08 | filing |
| 14 Sep 2015filed 16 Sep 2015 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Bought | $1,190175 at $6.80 | filing |
| 14 Nov 2014filed 17 Nov 2014 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Bought | $960200 at $4.80 | filing |
| 13 Nov 2014filed 17 Nov 2014 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Bought | $960200 at $4.80 | filing |
| 16 Sep 2014filed 17 Sep 2014 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Bought | $1,013225 at $4.50 | filing |
| 19 Aug 2014filed 22 Aug 2014 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Bought | $900200 at $4.50 | filing |
| 26 Jun 2014filed 30 Jun 2014 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Bought | $1,088250 at $4.35 | filing |
| 11 Jun 2014filed 13 Jun 2014 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Bought | $3,075750 at $4.10 | filing |
| 11 Jun 2014filed 13 Jun 2014 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Bought | $3,075750 at $4.10 | filing |
News
ImmuCell Announces a 46% Increase in Product Sales in Quarter Three of 2026, Based on Preliminary, Unaudited Sales ResultsICCC · manilatimes.net · 12 Oct 2026
0 headlines in the last 90 days name Paul R. Wainman; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.